MENU
+Compare
TKPHF
Stock ticker: OTC
AS OF
Oct 14 closing price
Price
$29.05
Change
+$1.72 (+6.29%)
Capitalization
43.83B

TKPHF stock forecast, quote, news & analysis

Takeda Pharmaceutical is Japan’s largest pharmaceutical company, with revenue of JPY 4... Show more

TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for TKPHF with price predictions
Oct 16, 2025

TKPHF in downward trend: 10-day moving average crossed below 50-day moving average on October 09, 2025

The 10-day moving average for TKPHF crossed bearishly below the 50-day moving average on October 09, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 23 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Aroon Indicator for TKPHF entered a downward trend on October 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TKPHF's RSI Oscillator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 15, 2025. You may want to consider a long position or call options on TKPHF as a result. In of 107 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TKPHF just turned positive on October 16, 2025. Looking at past instances where TKPHF's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

TKPHF moved above its 50-day moving average on October 14, 2025 date and that indicates a change from a downward trend to an upward trend.

TKPHF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.009) is normal, around the industry mean (17.684). P/E Ratio (51.278) is within average values for comparable stocks, (73.162). Projected Growth (PEG Ratio) (0.430) is also within normal values, averaging (2.099). Dividend Yield (0.047) settles around the average of (0.030) among similar stocks. P/S Ratio (1.571) is also within normal values, averaging (46.659).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly better than average price growth. TKPHF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TKPHF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

A.I.Advisor
published Dividends

TKPHF paid dividends on December 01, 2020

Takeda Pharmaceutical Co., Ltd. TKPHF Stock Dividends
А dividend of $90.00 per share was paid with a record date of December 01, 2020, and an ex-dividend date of September 29, 2020. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), BioCryst Pharmaceuticals (NASDAQ:BCRX), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 3.95B. The market cap for tickers in the group ranges from 2.12K to 63.85B. ZTS holds the highest valuation in this group at 63.85B. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was 1%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 53%. OVATF experienced the highest price growth at 117%, while MAJI experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was -36%. For the same stocks of the Industry, the average monthly volume growth was 41% and the average quarterly volume growth was 32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 64
Price Growth Rating: 81
SMR Rating: 100
Profit Risk Rating: 90
Seasonality Score: -1 (-100 ... +100)
View a ticker or compare two or three
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
1-1, Nihonbashi-Honcho 2-Chome
Phone
+81 332782306
Employees
49095
Web
https://www.takeda.com